Envista Holdings Corporation Common Stock (NVST)

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

A number of stocks jumped in the morning session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports, shifting the start date to July 9, 2025. 

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.

A number of stocks fell in the afternoon session after the major pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that could worsen the already wide US fiscal deficit. 

Dental products company Envista Holdings (NYSE:NVST) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 1.1% year on year to $616.9 million. Its non-GAAP profit of $0.24 per share was 17.1% above analysts’ consensus estimates.

A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains. 

Dental products company Envista Holdings (NYSE:NVST) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.1% year on year to $616.9 million. Its non-GAAP profit of $0.24 per share was 17.1% above analysts’ consensus estimates.

Dental products company Envista Holdings (NYSE:NVST) will be announcing earnings results tomorrow after market close. Here’s what investors should know.

Let’s dig into the relative performance of Dentsply Sirona (NASDAQ:XRAY) and its peers as we unravel the now-completed Q4 dental equipment & technology earnings season.

Over the last six months, Envista shares have sunk to $15.51, producing a disappointing 18.5% loss - worse than the S&P 500’s 8.1% drop. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Envista (NYSE:NVST) and the best and worst performers in the dental equipment & technology industry.

Let’s dig into the relative performance of Align Technology (NASDAQ:ALGN) and its peers as we unravel the now-completed Q4 dental equipment & technology earnings season.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Henry Schein (NASDAQ:HSIC) and the best and worst performers in the dental equipment & technology industry.

Dental products company Dentsply Sirona (NASDAQ:XRAY) will be announcing earnings results tomorrow morning. Here’s what you need to know.

Dental and Medical products company Henry Schein (NASDAQ:HSIC) will be reporting results tomorrow morning. Here’s what investors should know.

Medical technology company Edwards Lifesciences (NYSE:EW) will be reporting results tomorrow after market close. Here’s what to look for.

Dental products company Envista Holdings (NYSE:NVST) announced better-than-expected revenue in Q4 CY2024, with sales up 1.1% year on year to $652.9 million. Its non-GAAP profit of $0.24 per share was 9.9% above analysts’ consensus estimates.